Zenas Biopharma Inc (ZBIO) Stock Price, Quote & News

Company Profile

Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed to bind CD19 and Fc?RIIb for the treatment of various I&I diseases and various indications, including immunoglobulin G4-related disease, multiple sclerosis, and systemic lupus erythematosus. The company develops ZB002, an anti-TNFa monoclonal antibody; ZB004,...

Industry: Biotechnology

Sector: Healthcare

Phone: 857 271 2954

Website: zenasbio.com

Address:

852 Winter Street, Suite 250, Waltham, United States

CEOBuysDisclosures Apr. 30 at 1:25 AM

$ZBIO CEO purchased 60,000 shares at $17.79 for a total of $1,067,200. MOULDER LEON O JR now owns 2,246,122 shares. https://ceo-buys.com

0 · Reply

ScottYMoore Apr. 27 at 10:18 PM

$ZBIO over 10 million short 40%...ill keep accumulating

0 · Reply

gooders14 Apr. 24 at 8:33 PM

$ZBIO Triple bottom?

0 · Reply

PepCF Apr. 24 at 7:20 PM

$ZBIO IS holding in a critical zone. The $20 offering is still weighing it down, and the volume is negligible. The overall sector sentiment and the tensions in Iran aren't helping small caps that need to finance themselves. We'll see if the support holds or if the market continues the sell-off. Monitoring.

0 · Reply

4Reel Apr. 24 at 5:01 PM

$ZBIO it did get a bounce after the gap down, thanks to a lot of insider buying. This chart is since the year started so u can see its in a straight downtrend until further notice

1 · Reply

Kynoch Apr. 23 at 7:58 PM

$ZBIO Anybody know why it dropped?

0 · Reply

PepCF Apr. 23 at 7:07 PM

$ZBIO If the price closes below 17.50 at any point—which is the January low—I will sell everything.

0 · Reply

Kynoch Apr. 21 at 4:59 PM

$ZBIO https://www.biospace.com/press-releases/zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-april-17-2026

0 · Reply

PepCF Apr. 14 at 1:15 PM

$ZBIO

0 · Reply

TipRanks Apr. 7 at 10:52 AM

Insiders Are Scooping Up These 2 ‘Strong Buy’ Stocks https://www.tipranks.com/news/article/insiders-are-scooping-up-these-2-strong-buy-stocks $ZBIO $NAVN

0 · Reply

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 27, 2026, 12:12 AM EDT - 4 weeks ago

Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million

Mar 26, 2026, 4:01 PM EDT - 4 weeks ago

Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

Mar 16, 2026, 7:00 AM EDT - 6 weeks ago

Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Feb 11, 2026, 1:30 PM EST - 2 months ago

Zenas BioPharma Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026

Feb 9, 2026, 7:05 AM EST - 2 months ago

Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026

Feb 4, 2026, 7:05 AM EST - 3 months ago

Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Jan 22, 2026, 10:26 AM EST - 3 months ago

These 20 stocks are strong choices for momentum investors

BE CELC COGT FBYD FRGE INBX KOD

Jan 16, 2026, 4:15 PM EST - 3 months ago

Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jan 6, 2026, 7:38 AM EST - 4 months ago

Why Zenas BioPharma's Selloff Was Structurally Inevitable

Jan 5, 2026, 10:21 AM EST - 4 months ago

Zenas BioPharma Touts Phase 3 Win, But Stock Crashes

Jan 5, 2026, 8:29 AM EST - 4 months ago

Zenas BioPharma's immune disorder drug meets main goal in late-stage trial

Jan 5, 2026, 8:00 AM EST - 4 months ago

Zenas BioPharma Transcript: Study Result

Jan 5, 2026, 7:05 AM EST - 4 months ago

Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Dec 15, 2025, 7:05 AM EST - 4 months ago

Zenas BioPharma's Partner, InnoCare Pharma, Announces Achievement of Primary Endpoint in Phase 2b Study of Orelabrutinib, a BTK Inhibitor, for Systemic Lupus Erythematosus

Dec 3, 2025, 7:55 AM EST - 5 months ago

Zenas BioPharma Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 18, 2025, 6:00 AM EST - 5 months ago

Zenas BioPharma Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 7:05 AM EST - 6 months ago

Zenas BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 11, 2025, 7:05 AM EST - 6 months ago

Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences

Oct 27, 2025, 7:05 AM EDT - 6 months ago

Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis

Oct 8, 2025, 8:00 AM EDT - 7 months ago

Zenas BioPharma Transcript: Status Update

Oct 8, 2025, 6:04 AM EDT - 7 months ago

Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug

Oct 8, 2025, 5:00 AM EDT - 7 months ago

Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis

Sep 10, 2025, 7:45 AM EDT - 8 months ago

Zenas BioPharma Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 3, 2025, 8:35 AM EDT - 8 months ago

Zenas BioPharma Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 1:00 PM EDT - 8 months ago

Zenas BioPharma Transcript: Citi's Biopharma Back to School Conference

Sep 2, 2025, 7:05 AM EDT - 8 months ago

Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million

RPRX

Aug 12, 2025, 7:05 AM EDT - 9 months ago

Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

Jun 16, 2025, 3:44 AM EDT - 11 months ago

FINAL ALERT NOTICE - ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

Jun 15, 2025, 10:44 AM EDT - 11 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

Jun 12, 2025, 6:17 PM EDT - 11 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

Jun 11, 2025, 10:24 AM EDT - 11 months ago

ZBIO Shareholders Have the Right to Lead the Zenas Biopharma, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ZBIO

Jun 5, 2025, 1:25 PM EDT - 11 months ago

Zenas BioPharma Transcript: Jefferies Global Healthcare Conference 2025

May 31, 2025, 8:55 AM EDT - 11 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zenas BioPharma

May 29, 2025, 7:05 AM EDT - 1 year ago

Zenas BioPharma to Present at the Jefferies Global Healthcare Conference

Feb 5, 2025, 3:00 PM EST - 1 year ago

Zenas BioPharma Transcript: Guggenheim SMID Cap Biotech Conference

Dec 3, 2024, 9:30 AM EST - 1 year ago

Zenas BioPharma Transcript: Citi's 2024 Global Healthcare Conference

Nov 19, 2024, 11:00 AM EST - 1 year ago

Zenas BioPharma Transcript: Jefferies London Healthcare Conference 2024

CEOBuysDisclosures Apr. 30 at 1:25 AM

$ZBIO CEO purchased 60,000 shares at $17.79 for a total of $1,067,200. MOULDER LEON O JR now owns 2,246,122 shares. https://ceo-buys.com

0 · Reply

ScottYMoore Apr. 27 at 10:18 PM

$ZBIO over 10 million short 40%...ill keep accumulating

0 · Reply

gooders14 Apr. 24 at 8:33 PM

$ZBIO Triple bottom?

0 · Reply

PepCF Apr. 24 at 7:20 PM

0 · Reply

4Reel Apr. 24 at 5:01 PM

$ZBIO it did get a bounce after the gap down, thanks to a lot of insider buying. This chart is since the year started so u can see its in a straight downtrend until further notice

1 · Reply

Kynoch Apr. 23 at 7:58 PM

$ZBIO Anybody know why it dropped?

0 · Reply

PepCF Apr. 23 at 7:07 PM

$ZBIO If the price closes below 17.50 at any point—which is the January low—I will sell everything.

0 · Reply

Kynoch Apr. 21 at 4:59 PM

$ZBIO https://www.biospace.com/press-releases/zenas-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-april-17-2026

0 · Reply

PepCF Apr. 14 at 1:15 PM

$ZBIO

0 · Reply

TipRanks Apr. 7 at 10:52 AM

Insiders Are Scooping Up These 2 ‘Strong Buy’ Stocks https://www.tipranks.com/news/article/insiders-are-scooping-up-these-2-strong-buy-stocks $ZBIO $NAVN

0 · Reply

outlawinvestor1 Apr. 3 at 3:25 AM

$ZBIO insider confidence!

0 · Reply

OfficialStocktwitsUser Apr. 3 at 2:42 AM

$ZBIO RSI: 40.36, MACD: -1.2369 Vol: 2.37, MA20: 22.52, MA50: 23.03 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

SuperGreenToday Apr. 2 at 12:48 AM

$ZBIO Share Price: $20.34 Contract Selected: Dec 18, 2026 $20 Calls Buy Zone: $3.40 – $4.20 Target Zone: $5.55 – $6.79 Potential Upside: 54% ROI Time to Expiration: 260 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

FilingTracker Apr. 1 at 8:32 PM

$ZBIO More insider purchasing: https://www.sec.gov/Archives/edgar/data/1663607/000110465926038546/xslF345X06/tm2610877-1_4seq1.xml

0 · Reply

Smoka416 Apr. 1 at 4:45 PM

$ZBIO Huge insider buy whats the deal with this anyone informed on this name? fill me in chiefs

0 · Reply

outlawinvestor1 Apr. 1 at 7:20 AM

$ZBIO

0 · Reply

PaulLaurent Apr. 1 at 6:05 AM

🚀📈 Top Gainers 📈🚀AH $UCAR $NCNO $MGN $HUBC $ZBIO

0 · Reply

CEOBuysDisclosures Apr. 1 at 2:20 AM

$ZBIO CEO purchased 54,000 shares at $18.91 for a total of $1,021,140. MOULDER LEON O JR now owns 2,186,122 shares. https://ceo-buys.com

0 · Reply

focafoca99 Apr. 1 at 1:23 AM

$ZBIO completed a $200 million convertible notes offering, issuing 2.50% notes due 2032.

1 · Reply

FilingTracker Apr. 1 at 12:15 AM

$ZBIO CEO purchased more shares: https://www.sec.gov/Archives/edgar/data/1228865/000110465926038031/xslF345X06/tm2610818-1_4seq1.xml

0 · Reply

Juststartingout14 Mar. 31 at 10:20 PM

$ZBIO https://www.stocktitan.net/sec-filings/ZBIO/form-4-zenas-bio-pharma-inc-insider-trading-activity-e14f4cdafeee.html

0 · Reply

FilingTracker Mar. 31 at 9:04 PM

$ZBIO Large insider purchase through public offering, at $20/share: https://www.sec.gov/Archives/edgar/data/1767584/000110465926037865/xslF345X06/tm2610681-1_4seq1.xml

0 · Reply

Market Cap	1.03B
Revenue (ttm)	10.00M
Net Income (ttm)	-377.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,777.40%
Debt to Equity Ratio	0.32

Volume	495,700
Avg Vol	738,310
Day's Range	N/A - N/A
Shares Out	57.37M
Stochastic %K	3%
Beta	-0.54
Analysts	Strong Sell
Price Target	$42.00